60 Degrees Pharmaceutical... (SXTP)
undefined
undefined%
At close: undefined
1.40
1.45%
After-hours Dec 13, 2024, 07:50 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20
Revenue 253.57K 223.21K 1.16M 2.18M
Cost of Revenue 474.55K 432.37K 850.74K 702.99K
Gross Profit -220.98K -209.16K 309.60K 1.48M
Operating Income -5.15M -1.75M -1.12M -418.13K
Interest Income - - - -
Pretax Income -3.81M -6.18M -4.26M -3.05M
Net Income -3.77M -6.18M -4.25M -3.03M
Selling & General & Admin 4.24M 1.30M 1.12M 1.46M
Research & Development 691.77K 237.56K 318.35K 438.58K
Other Expenses - -43.24K 37.52K -121
Operating Expenses 4.93M 1.54M 1.43M 1.85M
Interest Expense 2.29M 3.99M 3.17M 2.68M
Selling & Marketing Expenses - - - -
Cost & Expenses 5.41M 1.97M 2.28M 2.55M
Income Tax 250.00 500.00 1K 1K
Shares Outstanding (Basic) 3.96M 5.78M 5.78M 5.78M
Shares Outstanding (Diluted) 3.96M 5.78M 5.78M 5.78M
EPS (Basic) -0.95 -1.07 -0.74 -0.52
EPS (Diluted) -0.95 -1.07 -0.74 -0.52
EBITDA -1.43M -2.11M -1.01M -341.17K
Depreciation & Amortization 100.37K 78.79K 71.78K 27.86K